Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.00% is 74% below its 5-year average of 7.61%, near the low end of its 5-year range (0.09%–16.61%).
As of the fiscal period ended Tuesday, June 30, 2026. 72.23% below its 12-month average of 7.20%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.00%.
DEBT TO ASSETS RATIO
2.00%
DEBT TO ASSETS RATIO AVG TTM
7.20%
DEBT TO ASSETS RATIO AVG 3Y
7.39%
DEBT TO ASSETS RATIO AVG 5Y
7.61%
DEBT TO ASSETS RATIO AVG 10Y
6.51%
DEBT TO ASSETS RATIO AVG 15Y
28.34%
DEBT TO ASSETS RATIO AVG 20Y
24.64%
CURRENT VS TTM AVG
-72.23%
CURRENT VS 3Y AVG
-72.94%
CURRENT VS 5Y AVG
-73.74%
CURRENT VS 10Y AVG
-69.31%
CURRENT VS 15Y AVG
-92.95%
CURRENT VS 20Y AVG
-91.89%
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 517 covered companies
CURRENT VS SECTOR MEDIAN
+1717.33%
vs the sector median at left
Dyne Therapeutics, Inc.
Market Cap
$2.85B
Debt to Assets Ratio
2.00%
TTM Avg
7.20%
3Y Avg
7.39%
5Y Avg
7.61%
Market Cap
$2.90B
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.76B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.69B
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.68B
Debt to Assets Ratio
0.46%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.68B
Debt to Assets Ratio
0.71%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.15B
Debt to Assets Ratio
0.23%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.16B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.85B | 2.00% | 7.20% | 7.39% | 7.61% |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 0.59% | N/A | N/A | N/A |
| AtriCure, Inc. (ATRC)vs › | $2.85B | 0.11% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | 0.18% | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.69B | 0.13% | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 0.46% | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 0.71% | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 0.23% | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | 0.02% | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.18B | 0.02% | N/A | N/A | N/A |
Debt/Assets
2.0%
Debt/Equity
0.03
Current Ratio
12.02
Interest Coverage
-75.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.00% |
| 2026-03-31 | 1.79% |
| 2025-12-31 | 1.71% |
| 2025-09-30 | 13.89% |
| 2025-06-30 | 16.61% |
| 2025-03-31 | 3.24% |
| 2024-12-31 | 3.47% |
| 2024-09-30 | 3.23% |
| 2024-06-30 | 3.11% |
| 2024-03-31 | 5.10% |
| 2023-12-31 | 16.61% |
| 2023-09-30 | 13.75% |
| 2023-06-30 | 11.55% |
| 2023-03-31 | 10.31% |
| 2022-12-31 | 9.95% |
| 2022-09-30 | 10.41% |
| 2022-06-30 | 9.66% |
| 2022-03-31 | 8.45% |
| 2021-12-31 | 7.67% |
| 2021-09-30 | 7.28% |
| 2021-06-30 | 0.09% |
| 2021-03-31 | 0.12% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 2.60% |
| 2020-06-30 | 6.78% |
| 2019-12-31 | 0.00% |
| 2017-12-31 | 71.64% |
| 2017-09-30 | 72.85% |
| 2017-06-30 | 73.02% |
| 2017-03-31 | 71.23% |
| 2016-12-31 | 68.79% |
| 2016-09-30 | 73.12% |
| 2016-06-30 | 72.22% |
| 2016-03-31 | 63.31% |
| 2015-12-31 | 63.17% |
| 2015-09-30 | 59.87% |
| 2015-06-30 | 58.70% |
| 2015-03-31 | 63.17% |
| 2014-12-31 | 63.27% |
| 2014-09-30 | 39.83% |
| 2014-06-30 | 38.70% |
| 2014-03-31 | 37.48% |
| 2013-12-31 | 37.65% |
| 2013-09-30 | 31.18% |
| 2013-06-30 | 31.21% |
| 2013-03-31 | 31.54% |
| 2012-12-31 | 31.20% |
| 2012-09-30 | 28.09% |
| 2012-06-30 | 1050.42% |
| 2012-03-31 | 14.25% |
| 2011-12-31 | 14.25% |
| 2011-09-30 | 45.14% |
| 2011-06-30 | 49.28% |
| 2011-03-31 | 46.58% |
| 2010-12-31 | 45.68% |
| 2010-09-30 | 41.43% |
| 2010-06-30 | 43.47% |
| 2010-03-31 | 1.10% |
| 2009-12-31 | 14.74% |
| 2009-09-30 | 1.00% |
| 2009-06-30 | 1.37% |
| 2009-03-31 | 0.91% |
| 2008-12-31 | 0.90% |
| 2008-09-30 | 0.80% |
| 2008-06-30 | 0.69% |
| 2008-03-31 | 0.69% |
| 2007-12-31 | 0.77% |
| 2007-09-30 | 0.79% |
| 2007-06-30 | 0.81% |
